Literature DB >> 16014646

The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.

Carsten Tschöpe1, Mario Kasner, Dirk Westermann, Regina Gaub, Wolfgang C Poller, Heinz-Peter Schultheiss.   

Abstract

AIMS: Diastolic heart failure is a frequent entity but difficult to diagnose. N-terminal pro-B type natriuretic peptide (NT-proBNP) was therefore investigated as a possible non-invasive parameter to diagnose isolated diastolic dysfunction. METHODS AND
RESULTS: Sixty-eight symptomatic patients with isolated diastolic dysfunction and preserved left ventricular ejection fraction (LVEF) (> or =50%) and 50 patients with regular left ventricular (LV) function were examined by conventional echocardiography, tissue Doppler imaging (TDI), and left and right heart catheterization. Plasma NT-proBNP levels were determined simultaneously. Median NT-proBNP plasma levels were elevated [189.54 pg/mL (86.16-308.27) vs. 51.89 pg/mL (29.94-69.71); P<0.001] and increased with greater severity of the diastolic dysfunction (R=0.67, P<0.001). According to the recevier operating characteristic analysis, LV end-diastolic pressure [area under the curve (AUC) 0.84] was the most specific parameter, which had a low sensitivity (61%), however. The reliability of NT-proBNP was similar to TDI indices (AUC 0.83 vs. 0.81) and improved when compared with conventional echocardiography (AUC 0.59-0.70). NT-proBNP levels had the best negative predictive value of all methods (94%) and correlated strongly with indices of LV filling pressure, as determined by invasive measurements. Multivariable linear regression analysis confirmed NT-proBNP as an independent predictor of diastolic dysfunction with an Odds ratio of 1.2 (1.1-1.4, CI 95%) for every unit increase of NT-proBNP.
CONCLUSION: NT-proBNP can reliably detect the presence of isolated diastolic dysfunction in symptomatic patients and is an useful tool to rule out patients with reduced exercise tolerance of non-cardiac origin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014646     DOI: 10.1093/eurheartj/ehi406

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  61 in total

1.  Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.

Authors:  J Gustav Smith; Christopher Newton-Cheh; Peter Almgren; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Pyotr G Platonov; Bo Hedblad; Gunnar Engström; Thomas J Wang; Olle Melander
Journal:  J Am Coll Cardiol       Date:  2010-11-16       Impact factor: 24.094

2.  Prolonged mechanical systole and increased arterial wave reflections in diastolic dysfunction.

Authors:  T Weber; J Auer; M F O'Rourke; C Punzengruber; E Kvas; B Eber
Journal:  Heart       Date:  2006-05-18       Impact factor: 5.994

3.  Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab.

Authors:  Lu Cao; Gang Cai; Cai Chang; Ai-Yu Miao; Xiao-Li Yu; Zhao-Zhi Yang; Jin-Li Ma; Qian Zhang; Jiong Wu; Xiao-Mao Guo; Jia-Yi Chen
Journal:  Oncologist       Date:  2015-05-01

4.  Amino-terminal pro-brain natriuretic peptid in prediction of left ventricular ejection fraction.

Authors:  Mugdim Bajrić; Fahir Baraković; Zumreta Kusljugić; Nermin Salkić; Elmir Jahić; Mensura Ascerić; Farid Ljuca; Denis Mrsić; Elnur Smajić; Jasmin Caluk; Ramiz Hajrić
Journal:  Bosn J Basic Med Sci       Date:  2008-08       Impact factor: 3.363

5.  A novel global strain diastolic index correlates with plasma NT-proBNP levels in asymptomatic hypertensive patients with preserved left ventricular ejection fraction.

Authors:  Shuo-Ju Chiang; Masao Daimon; Katsuhisa Ishii; Sakiko Miyazaki; Yoko Koiso; Hiromasa Suzuki; Katsumi Miyauchi; Bei Yang; Mei-Hsiu Yeh; Betau Hwang; Hiroyuki Daida
Journal:  J Echocardiogr       Date:  2012-04-24

6.  Long-term outcome of patients with triphasic mitral flow with a mid-diastolic L wave: prognostic role of left atrial volume and N-terminal pro-brain natriuretic peptide.

Authors:  Sung-Ai Kim; Jungwoo Son; Chi-Young Shim; Eui-Young Choi; Jong-Won Ha
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-27       Impact factor: 2.357

7.  Association of CMR-measured LA function with heart failure development: results from the MESA study.

Authors:  Mohammadali Habibi; Harjit Chahal; Anders Opdahl; Ola Gjesdal; Thomas M Helle-Valle; Susan R Heckbert; Robyn McClelland; Colin Wu; Steven Shea; Gregory Hundley; David A Bluemke; João A C Lima
Journal:  JACC Cardiovasc Imaging       Date:  2014-05-07

Review 8.  Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

Authors:  A Palazzuoli; M Gallotta; I Quatrini; R Nuti
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

Review 9.  The heart failure epidemic.

Authors:  Véronique L Roger
Journal:  Int J Environ Res Public Health       Date:  2010-04-19       Impact factor: 3.390

10.  The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction.

Authors:  Raoul Stahrenberg; Frank Edelmann; Meinhard Mende; Anke Kockskämper; Hans-Dirk Düngen; Claus Lüers; Lutz Binder; Christoph Herrmann-Lingen; Götz Gelbrich; Gerd Hasenfuss; Burkert Pieske; Rolf Wachter
Journal:  Eur J Heart Fail       Date:  2010-09-13       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.